Research Article

Hemangiopericytoma: Incidence, Treatment, and Prognosis Analysis Based on SEER Database

Table 1

Clinicopathological characteristics of hemangiopericytoma and hemangioendothelioma patients.

Factor, (%)Hemangiopericytoma ()Hemangioendothelioma ()

Year (%)1975-1986118 (9.5)86 (37.2)<0.001
1987-1996146 (11.7)38 (16.5)
1997-2006392 (31.5)48 (20.8)
2007-2016587 (47.2)59 (25.5)
Age (years)Median5750<0.001
Mean55.149.3
Range0-980-97
Size (mm)Median7833<0.001
Mean97.942.1
Range0-9893-190
Sex (%)Male583 (46.9)120 (51.9)0.159
Female660 (53.1)111 (48.1)
Race/ethnicity (%)White1000 (81.3)180 (77.9)0.731
Black114 (9.3)22 (9.5)
Other116 (9.4)29 (12.5)
Surgery (%)Yes1090 (87.7)136 (58.9)<0.001
No153 (12.3)95 (41.1)
Chemotherapy (%)Yes153 (12.3)49 (21.2)<0.001
No1090 (87.7)182 (78.8)
Radiotherapy (%)Yes442 (35.9)52 (22.5)<0.001
No788 (64.1)179 (77.5)
Incidence (2016)0.0600.014
Annual percentage change (2000-2016)0.023-0.259

value less than 0.05 is statistically significant.